|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.470 USD | -21.45% |
|
-25.67% | +1.49% |
| 06-29 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Karyopharm Therapeutics Inc.(NasdaqGS:KPTI) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 169M 148M 137M 126M 238M 16.33B 242M 1.64B 643M 7.99B 636M 622M 27.52B | P/E 2026 * |
-1.79x | P/E 2027 * | -2.41x |
|---|---|---|---|---|---|
| Enterprise Value | 422M 370M 342M 315M 594M 40.72B 603M 4.09B 1.6B 19.92B 1.59B 1.55B 68.65B | EV / Sales 2026 * |
3.08x | EV / Sales 2027 * | 1.09x |
| Free-Float |
95.32% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Karyopharm Therapeutics Inc.
| 1 day | -21.45% | ||
| 1 week | -25.67% | ||
| Current month | -23.54% | ||
| 1 month | -17.18% | ||
| 3 months | -16.44% | ||
| 6 months | +25.55% | ||
| Current year | +1.49% |
| 1 week | 6.48 |  | 9.86 |
| 1 month | 6.48 | | 10.86 |
| Current year | 5 | | 10.99 |
| 1 year | 3.65 | | 10.99 |
| 3 years | 3.51 | | 29.25 |
| 5 years | 3.51 | | 220.95 |
| 10 years | 3.51 | | 444.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Paulson
CEO | Chief Executive Officer | 58 | 03/05/2021 |
Lori Macomber
DFI | Director of Finance/CFO | 55 | 03/01/2025 |
Amama Sadiq
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Barry Greene
BRD | Director/Board Member | 62 | 01/01/2013 |
| Director/Board Member | 61 | 01/04/2013 | |
Garen Bohlin
BRD | Director/Board Member | 78 | 03/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/21/26 A | Free | Director | 15,508 | 0.0688% | ||
| 5/21/26 A | Free | Director | 15,508 | 0.0688% | ||
| 5/21/26 A | Free | Director | 15,508 | 0.0688% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -21.45% | -25.67% | +94.03% | -69.07% | 169M | |
| -0.67% | +1.37% | +23.89% | -7.04% | 68.38B | |
| +0.13% | +2.49% | +37.51% | +190.54% | 51.69B | |
| -3.65% | +34.50% | +34.50% | +34.50% | 42.1B | |
| -1.00% | -1.28% | -52.46% | -54.56% | 41.11B | |
| -2.93% | -4.34% | +59.97% | -27.21% | 29.52B | |
| -3.77% | -11.22% | +90.31% | -52.32% | 23.6B | |
| -1.36% | +1.24% | +70.42% | +80.67% | 23.1B | |
| +0.11% | +2.67% | +4.29% | +181.86% | 20.54B | |
| -0.04% | +1.85% | +71.90% | +121.88% | 16.53B | |
| Average | -3.48% | -3.70% | +43.44% | +39.93% | 31.67B | |
| Weighted average by Cap. | -1.41% | -0.88% | +30.59% | +44.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 137M 120M 111M 102M 193M 13.23B 196M 1.33B 521M 6.47B 515M 504M 22.3B | 155M 136M 126M 116M 218M 14.98B 222M 1.5B 590M 7.33B 583M 570M 25.24B |
| Net income | -121M -106M -98.05M -90.18M -170M -11.67B -173M -1.17B -460M -5.71B -454M -445M -19.67B | -135M -118M -109M -100M -189M -12.97B -192M -1.3B -511M -6.35B -505M -494M -21.87B |
| Net Debt | 253M 222M 205M 189M 356M 24.4B 361M 2.45B 961M 11.94B 950M 929M 41.13B | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | $7.470 | -21.45% | 2,330,172 |
| 17/07/26 | $9.510 | +1.39% | 205,243 |
| 16/07/26 | $9.380 | -1.57% | 236,381 |
| 15/07/26 | $9.530 | -4.80% | 316,488 |
| 14/07/26 | $10.01 | -0.40% | 481,544 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KPTI Stock
Select your edition
All financial news and data tailored to specific country editions
